AFC (AFCG) Q2 2026 earnings review
NAV Expands on Massive Buybacks Despite Core Earnings Dip
AFC's first full quarter operating strictly as a BDC delivered a mixed outcome. On the positive side, the portfolio resumed growth ($289.8M at fair value) fueled by $17.2M in gross fundings, and NAV jumped sequentially from $7.90 to $8.25. However, this NAV growth was heavily engineered by aggressive share repurchases (buying at $3.29) rather than organic earnings. Core profitability is decelerating: Total Investment Income fell 11% sequentially to $8.7M, and Net Investment Income (NII) dropped from $0.21 to $0.15 per share. While the pivot away from legacy cannabis is stabilizing the balance sheet, lower yields on new middle-market loans are visibly pressuring earnings power.
🐂 Bull Case
Management repurchased 839k shares at a >50% discount to NAV ($3.29 average price). This aggressive action instantly generated $0.17 per share of pure NAV accretion, directly enriching remaining shareholders.
After quarters of deliberate portfolio contraction to shed cannabis risk, investments at fair value grew sequentially to $289.8M, signaling successful deployment into new, non-cannabis lower-middle market targets.
🐻 Bear Case
NII fell 28% sequentially to $0.15. If the new portfolio yield (13.2%) remains significantly lower than legacy high-teen cannabis debt, overall earnings will remain structurally pressured.
Net debt-to-equity increased from 0.48x to 0.53x. While still within reasonable bounds, rising leverage limits future dry powder as the company transitions its book.
⚖️ Verdict: ⚪
Neutral. The financial engineering is excellent and NAV growth is undeniable, but a sequential drop in core NII while the portfolio grows highlights the structural earnings headwind of transitioning from high-yield cannabis to standard middle-market debt.
Key Themes
Deep-Discount Share Repurchases Drive Value
The newly authorized $5.0M share repurchase program is the immediate growth engine for the stock's book value. By deploying ~$2.8M to retire 839,406 shares at a weighted average price of $3.29, AFC capitalized on a massive market disconnect, driving $0.17 of the quarter's $0.35 NAV increase. With ~$2.2M remaining on the authorization, this remains a potent driver.
Resumption of Portfolio Growth
Reversing a multi-quarter trend of capital contraction, the investment portfolio grew sequentially from $279.2M to $289.8M at fair value. With gross fundings of $17.2M outpacing $9.2M in repayments, AFC is proving it can actively originate deals under its new generalist mandate.
Tech-Enabled Portfolio Diversification
The portfolio's product composition is rapidly shifting from physical cannabis facilities to tech-enabled services. Building on prior quarter deployments into platforms like Stat (an AI-adjacent B2B revenue recovery software) and virtual healthcare networks, the new Q2 fundings continue to upgrade AFC's collateral quality from real estate to cash-flowing technology.
NII Decelerates Despite Portfolio Growth
A concerning contradiction emerged this quarter: while the investment portfolio grew, Total Investment Income fell 11% to $8.7M, and NII dropped from $0.21 to $0.15 per share. Management's narrative of a highly accretive BDC transition is challenged by this negative operating leverage. The 13.2% weighted average yield indicates new loans carry lower rates than legacy assets, structurally pressuring core earnings.
Capitalizing on Lower Middle-Market Void
On the macro front, AFC is exploiting a structural credit void in the lower middle-market ($5M-$50M EBITDA). As larger lenders move up-market to chase scale, AFC is securing favorable terms, originating 100% senior secured first-lien debt while maintaining a solid double-digit portfolio yield.
Legacy Cannabis Black Box Persists
In prior quarters, management confirmed the massive Justice Grown cannabis loan officially entered maturity default on May 1, 2026. The Q2 earnings release remains entirely silent on recovery status or potential write-downs, leaving investors blind to the largest potential source of realized losses.
Liquidity Metrics Tightening
While total liquidity remains adequate at over $70M, cash and cash equivalents dropped sequentially from $112.7M to $106.5M. Consequently, net debt-to-equity increased from 0.48x to 0.53x. As AFC ramps up deployments, further leverage increases will warrant monitoring.
Other KPIs
Accelerating sequentially from $7.90 in Q1 2026 and $7.46 at year-end 2025. The Q2 increase was driven by $0.15 in NII, $0.08 in net unrealized appreciation, and $0.17 from accretive repurchases, less the $0.05 quarterly dividend.
Stable buffer to execute the BDC transition, though down from the $100M+ levels observed in recent quarters as capital is actively deployed into the $1.5B+ pipeline.
Guidance
Stable. The board authorized $5.0M in May 2026, expiring May 2027. With ~$2.8M aggressively spent in Q2 alone, management retains significant firepower to force NAV accretion if shares continue to trade at deep discounts.
Stable. Maintained at the re-based level established post-REIT conversion, fully covered by the $0.15 NII generated in the quarter.
Key Questions
NII Decline Mechanics
What were the specific drivers behind the $1.1M sequential decline in Total Investment Income despite a net increase in portfolio fair value? Was this purely a yield-compression issue?
Justice Grown Resolution
It has been months since the Justice Grown loan entered maturity default. What is the status of the vertical assets in New Jersey and Pennsylvania, and should investors expect further CECL provisions?
New Origination Yields
What was the specific weighted average yield on the $17.2M of gross fundings this quarter, and how does it compare to the 13.2% portfolio average?
Buyback Cadence
Given the massive $0.17 NAV accretion generated in a single quarter, will the remaining $2.2M repurchase authorization be executed with the same aggressive cadence in Q3?